UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.485-494

2009

Volltextzugriff (PDF)

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

British journal of cancer, 2011-01, Vol.104 (2), p.265-271

2011

Volltextzugriff (PDF)

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

Leukemia, 2009-02, Vol.23 (2), p.305-312

2009

Volltextzugriff (PDF)

A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma

Clinical cancer research, 2005-08, Vol.11 (15), p.5504-5514

2005

Volltextzugriff (PDF)

Reduction of placental nitric oxide synthase activity in pre-eclampsia

Clinical science (1979), 1997-07, Vol.93 (1), p.51

1997

Volltextzugriff (PDF)

Human placental nitric oxide synthase activity is not altered in diabetes

Clinical science (1979), 1999-07, Vol.97 (1), p.123

1999

Volltextzugriff (PDF)

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

Haematologica (Roma), 2012-02, Vol.97 (2), p.227-234

2012

Volltextzugriff (PDF)

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer

European journal of cancer (1990), 2006-03, Vol.42 (5), p.621-628

2006

Volltextzugriff (PDF)

Optimization of a pharmacophore model for 5-HT4 agonists using CoMFA and receptor based alignment

European journal of medicinal chemistry, 2006, Vol.41 (1), p.16-26

2006

Volltextzugriff (PDF)

Effects of ATP, ADP, thrombin, vasopressin and U46619 on human placental nitric oxide synthase activity

Methods and findings in experimental and clinical pharmacology, 1997-10, Vol.19 (8), p.509

1997

Volltextzugriff (PDF)

ROLE OF UTERINE FACTORS IN THE DEVELOPMENT OF HYPERTENSION IN SHR

Clinical and experimental pharmacology & physiology, 1994-03, Vol.21 (3), p.239-242

1994

Volltextzugriff (PDF)

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Blood, 2012-08, Vol.120 (8), p.1570-1580

2012

Volltextzugriff (PDF)

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

Pharmacogenetics and genomics, 2009-04, Vol.19 (4), p.300-309

2009

Volltextzugriff (PDF)

Estimating the net contribution of interleukin‐28B variation to spontaneous hepatitis C virus clearance

Hepatology (Baltimore, Md.), 2011-05, Vol.53 (5), p.1446-1454

2011

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.2959-2966

2012

Volltextzugriff (PDF)

Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2010-01, Vol.19 (1), p.265-274

2010

Volltextzugriff (PDF)

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Pharmacogenetics and genomics, 2010-04, Vol.20 (4), p.217-230

2010

Volltextzugriff (PDF)

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study

The Journal of infectious diseases, 2011-01, Vol.203 (2), p.246-257

2011

Volltextzugriff (PDF)

A Randomized, Double-Blind, Crossover Trial of the Effect of Oxygen on Dyspnea in Patients with Advanced Cancer

Journal of pain and symptom management, 2006-12, Vol.32 (6), p.541-550

2006

Volltextzugriff (PDF)

Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4228-4235

2006

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Female
(17)
Adult
(13)
Middle Aged
(13)
Male
(12)
Aged
(9)
Pharmacology. Drug Treatments
(9)
Pharmacology & Pharmacy
(7)
Oncology
(6)
Pharmacogenetics
(6)
Aged, 80 And Over
(4)
Alleles
(4)
Anti-Hiv Agents - Pharmacokinetics
(4)
Hematologic And Hematopoietic Diseases
(4)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(4)
Treatment Outcome
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma

Reduction of placental nitric oxide synthase activity in pre-eclampsia

Human placental nitric oxide synthase activity is not altered in diabetes

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer

Optimization of a pharmacophore model for 5-HT4 agonists using CoMFA and receptor based alignment

Effects of ATP, ADP, thrombin, vasopressin and U46619 on human placental nitric oxide synthase activity

ROLE OF UTERINE FACTORS IN THE DEVELOPMENT OF HYPERTENSION IN SHR

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

Estimating the net contribution of interleukin‐28B variation to spontaneous hepatitis C virus clearance

Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals

Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study

A Randomized, Double-Blind, Crossover Trial of the Effect of Oxygen on Dyspnea in Patients with Advanced Cancer

Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination

Aktive Filter

Suchergebnisse filtern